DOI: 10.1007/s00259-018-4191-0Pages: 1-3

Value proposition of PSMA-targeted α–particle radioligand therapy in metastatic prostate cancer

1. University of Southern California, Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine

Correspondence to:
Hossein Jadvar
Tel: 323-442-1107
Email: jadvar@med.usc.edu

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Oct 4, 2018
  • Online: Oct 11, 2018

Article Tools

eanm
EJNMMI Ad